285 related articles for article (PubMed ID: 16301681)
1. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
J Immunol; 2005 Dec; 175(11):7708-18. PubMed ID: 16301681
[TBL] [Abstract][Full Text] [Related]
2. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
[TBL] [Abstract][Full Text] [Related]
3. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
J Clin Invest; 2004 Jan; 113(2):253-64. PubMed ID: 14722617
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Tamaki K
Am J Pathol; 2006 Feb; 168(2):499-510. PubMed ID: 16436664
[TBL] [Abstract][Full Text] [Related]
5. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.
Asano Y; Ihn H; Jinnin M; Mimura Y; Tamaki K
J Invest Dermatol; 2006 Aug; 126(8):1761-9. PubMed ID: 16675963
[TBL] [Abstract][Full Text] [Related]
6. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
[TBL] [Abstract][Full Text] [Related]
8. Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Yamane K; Tamaki K
J Invest Dermatol; 2005 Feb; 124(2):324-30. PubMed ID: 15675950
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase is involved in alpha2(I) collagen gene expression in normal and scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
J Immunol; 2004 Jun; 172(11):7123-35. PubMed ID: 15153536
[TBL] [Abstract][Full Text] [Related]
13. 5-HT
Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype.
Kawakami T; Ihn H; Xu W; Smith E; LeRoy C; Trojanowska M
J Invest Dermatol; 1998 Jan; 110(1):47-51. PubMed ID: 9424086
[TBL] [Abstract][Full Text] [Related]
15. Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts.
Ihn H; Yamane K; Tamaki K
J Invest Dermatol; 2005 Aug; 125(2):247-55. PubMed ID: 16098034
[TBL] [Abstract][Full Text] [Related]
16. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
17. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
18. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
Jinnin M; Ihn H; Tamaki K
Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblasts.
Chen Y; Leask A; Abraham DJ; Pala D; Shiwen X; Khan K; Liu S; Carter DE; Wilcox-Adelman S; Goetinck P; Denton CP; Black CM; Pitsillides AA; Sarraf CE; Eastwood M
Arthritis Rheum; 2008 Feb; 58(2):577-85. PubMed ID: 18240216
[TBL] [Abstract][Full Text] [Related]
20. Decreased integrin alpha 2, but normal response to TGF-beta in scleroderma fibroblasts.
Osada K; Seishima M; Kitajima Y; Yaoita H; Mori S
J Dermatol Sci; 1995 May; 9(3):169-75. PubMed ID: 8664214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
